TipRanks
Go Ultimate55% OFF

Neurocrine (NB3) Revenue

Neurocrine Revenue

Neurocrine had a revenue of 959.00M in the quarter ending Jun 30, 2026, with 17.74%. This bring the company's revenue in the last twelve months to 3.37B, Increased 8.75%. In the fiscal year ending Dec 31, 2025, Neurocrine had annual revenue of 2.86B with 21.45% growth.

Revenue (ttm)
3.37B
Revenue Growth
25.50%
P/S Ratio
4.65
Revenue/Employee
EUR 1,144,200
Employees
2,500
Market Cap
EUR 13.30B

Revenue Chart

Neurocrine Revenue - Annual

0500M1B1.5B2B2.5B3B3.5B161.63M451.20M788.10M1.05B1.13B1.49B1.89B2.36B2.86B201720182019202020212022202320242025
Revenue History
Download to Excel
DE:NB3 revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20252.86B505.20M21.45%
Dec 31, 20242.36B468.20M24.81%
Dec 31, 20231.89B398.40M26.76%
Dec 31, 20221.49B355.20M31.34%
Dec 31, 20211.13B87.60M8.38%
Dec 31, 20201.05B257.80M32.71%
Dec 31, 2019788.10M336.90M74.67%
Dec 31, 2018451.20M289.57M179.16%
Dec 31, 2017161.63M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
DE:NB33.37B
ACAD1.14B
XENE0.00
AXSM776.57M
HRMY959.90M
PRAX0.00